October 24th 2024
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
Mixed results for intensive blood-sugar control
June 7th 2012Intensive control of blood-sugar levels among patients with type 2 diabetes mellitus may reduce the risk of microalbuminuria and macroalbuminuria, signs of kidney damage, but evidence is lacking regarding the effect over renal end points, according to the results of a study published May 28 in Archives of Internal Medicine.
Walgreens: Pharmacist face-time aids statin adherence
June 5th 2012Patients taking statins for the first time demonstrated better medication adherence if they participated in face-to-face counseling sessions with a community pharmacist than patients who did not, according to a new study by Walgreens.
Walgreens, OptumRx extend access arrangement
June 4th 2012Walgreens, the nation's largest drugstore chain, and OptumRx, one of the largest pharmacy benefit managers in the United States, today announced they will extend a multi-year agreement that provides access to OptumRx's members at Walgreens' 7,800 locations.
CPhA endorses California's Prop 29 cigarette tax
May 30th 2012The California Pharmacists Association (CPhA) announced Tuesday that its board of trustees has endorsed the California Cancer Research Act, also known as Proposition 29, which would raise $735 million annually for cancer research and smoking education by imposing a $1 tax on a pack of cigarettes
Study: E-prescribing increase helps adherence, costs
May 29th 2012The number of physicians and clinicians using e-prescribing increased by 67% in 2011 and they filled 75% more medication orders electronically, according to a new downloadable report by Surescripts, which operates a nationwide network connecting the computer systems of physicians and pharmacies.
Post-PCI bleeding reduced with changes in strategy
May 24th 2012Changes in procedural antithrombotic strategy are associated with a significant temporal reduction in major bleeding over time in patients undergoing elective post-percutaneous intervention, according to a study published in the Journal of the American College of Cardiology.
Atypical antipsychotics may help major depression
May 24th 2012The use of atypical antipsychotics in patients with major depressive disorder who have not responded to antidepressant therapy substantially increased clinical response rates at 6 weeks; however the drugs are also much more costly, according to the results of an analysis published in the May issue of The Annals of Pharmacotherapy.
First-line drugs for diabetes not always chosen
May 24th 2012More than a third of patients newly diagnosed with diabetes mellitus did not receive the recommended first-line drug, a finding that could have substantial implications for healthcare spending, according to a study published in the American Journal of Medicine.
3 pharmacy schools honored by Educators Challenge
May 22nd 2012The University of Arizona College of Pharmacy, the University of Maryland School of Pharmacy, and The Ohio State University College of Pharmacy won the first Innovative Adherence Educators Challenge for the best practices in medication adherence teaching.
Study: Zithromax associated with cardiovascular deaths; FDA reviewing
May 18th 2012FDA has notified healthcare professionals that it is aware of a study published in the New England Journal of Medicine reporting a small increase in cardiovascular deaths and in the risk of death from any cause in persons treated with a 5-day course of azithromycin (Zithromax) compared to persons treated with amoxicillin, ciprofloxacin, or no drug.
Warfarin, aspirin similar in treating heart failure
May 17th 2012Warfarin fared no better than aspirin at reducing the combined risk of brain hemorrhage, stroke, or death for heart-failure patients in normal rhythm, according to the results of a study published in the New England Journal of Medicine.
Variation in schizophrenia treatment
May 17th 2012Patients with schizophrenia who switched from haloperidol decanoate or fluphenazine decanoate to risperidone microspheres discontinued their treatment more frequently, according to a new study published in the March issue of the Journal of Clinical Psychiatry.